Sun Pharmaceuticals

BSE : 524715 | NSE : SUNPHARMA
Industry : Pharmaceuticals | ISIN : INE044A01036 | FreeFloat : 44.29% | FnO : Yes | LotSize : 700
Intellectual Capital (IC)62,816.16
Net Worth (NW)59,205.13
Intrinsic Worth (IW)122,021.30
Market Cap (MC)240,269.40
Economic Value Added198.79
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)51.48%
IC Gross Margin (EBITDA/IC)16.94%
IC Net Margin (NPT/IC)11.11%
Knowledge Turnover (Sales/IC)0.64
Market to Intrinsic Value (MC/IW)1.97
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 508.56Rs. 1,001.40
20 Mar 2023 ---- Rs. 961.20
3.50     0.36%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 958.00BuyStrong Buy
KB > 50% : Yes50 DMA : Rs. 998.66
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
8184.94
8287.17
1204.60
629.22
577.44
492.76
1741.44
Jun-20
C
7585.25
7739.04
-1636.03
-2131.95
-2183.90
-1655.60
-2055.18
Sep-20
C
8553.13
8808.91
2449.06
1950.46
1917.18
1812.79
1315.10
Dec-20
C
8836.78
9151.73
2721.09
2189.15
2163.05
1852.48
1640.72
Mar-21
C
8522.98
8633.98
1486.63
933.14
903.04
894.15
782.67
Jun-21
C
9718.74
9871.26
2342.53
1839.31
1804.22
1444.17
2003.43
Sep-21
C
9625.93
9848.82
2852.83
2322.46
2286.51
2047.01
1863.12
Dec-21
C
9863.06
10295.57
3038.84
2485.16
2466.19
2058.80
2034.12
Mar-22
C
9446.76
9560.35
2448.94
1892.47
1855.13
-2277.25
-1899.47
Jun-22
C
10761.76
10763.90
2884.07
2296.07
2282.38
2093.39
3071.46
Sep-22
C
10952.28
11037.50
3037.50
2427.55
2408.16
2262.22
2948.31
Dec-22
C
11240.97
11414.85
3170.31
2510.36
2464.18
2166.01
2841.02
* C - Consolidated, S - Standalone